
Loading, please wait...

Loading, please wait...

This prospective randomized pilot trial compared lacosamide with pregabalin in adults with chronic neuropathic pain. Of 72 screened patients, 36 were randomized and 29 completed the study. After 3 months, mean NRS pain scores decreased from 7.7 to 2.50 with lacosamide versus 7.6 to 4.27 with pregabalin (P<0.001). Both treatments significantly improved all SF-36 quality-of-life domains (P<0.001), with no significant between-group difference in overall quality of life. No serious adverse drug reactions occurred. Lacosamide produced greater pain reduction but was more costly because of twice-daily dosing.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This prospective randomized pilot trial compared lacosamide with pregabalin in adults with chronic neuropathic pain. Of 72 screened patients, 36 were randomized and 29 completed the study. After 3 months, mean NRS pain scores decreased from 7.7 to 2.50 with lacosamide versus 7.6 to 4.27 with pregabalin (P<0.001). Both treatments significantly improved all SF-36 quality-of-life domains (P<0.001), with no significant between-group difference in overall quality of life. No serious adverse drug reactions occurred. Lacosamide produced greater pain reduction but was more costly because of twice-daily dosing.
last month

A multicenter study validates a machine learning-guided recalibrated SOFA score, demonstrating significantly improved ICU mortality discrimination while preserving the simple, additive, point-based structure critical for bedside decision-making.
Yesterday

A landmark study reveals that lipid-rich malignant ascites alters the T-cell metabolic transcriptome, causing cholesterol efflux and impaired fatty acid oxidation. This suppresses TCR signalling and blocks BiTE immunotherapy, while lipid depletion restores antitumour cytotoxicity in ovarian cancer.
Yesterday

Researchers have engineered novel light-on photoswitchable adrenoceptor agonists targeting β1-receptors. By remaining inactive until illuminated, these precision molecules offer reversible optical control, tailored relaxation kinetics, and distinct efficacy profiles, paving the way for targeted cardiovascular therapies.
2 days back

A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 weeks back

This review examines the pharmacogenomics of antidiabetic agents, highlighting how genetic variations in SLC2A2, SLC47A1, CYP2C9, ABCC8, and GLP1R influence drug transport, therapeutic efficacy, and hypoglycemia risk to enable tailored precision medicine in type 2 diabetes.
Yesterday